A Danish research institution owns a patent on compositions and methods for treatment and diagnosis of neurodegenerative diseases (Parkinson's disease). The invention will give opportunity to identify novel neuroprotective targets in the group of neurodegenerative based on identified gene responses, and identify novel biomarkers of disease development and progression. The group is looking for licence agreement or joint further development.